Drug Topics - October 22, 2007 - (Page H23) www.drugtopics.com OCTOBER 22, 2007 DRUG TOPICS HSE 23 Professional Practice Premier launches comprehensive quality improvement project Martin Sipkoff A new project by the healthcare alliance Premier Inc. coronary artery bypass graft, pneumonia, and hip and is an aggressive attempt to develop performance knee replacement. The initial phase of the program will measures that “achieve quality and lower costs si- focus on mortality, appropriate care, and efficiency, with multaneously through utilization of specific performance harm avoidance and patient satisfaction the focus in measures,” said Dan Peterson, M.D., VP and medical di- Year 2. CMS awarded $8.7 million in incentive payments rector of Premier, a San Diego-based nationwide alliance earlier this year to the top hospitals in the program. of about 1,700 not-for-profit hospitals. “We can’t achieve The emphasis on relating quality and cost reflects the this without the active participation of pharmacists.” findings of an analysis Premier conducted of the HQID “Among the practitioners in a hospital, only one is project: Had all pneumonia, heart bypass, heart attack specifically trained to focus on medication use, and that’s (acute myocardial infarction), and hip and knee replacethe pharmacist,” said Kasey Thompson, Pharm.D., direc- ment patients nationally received most or all of the tor of patient safety at ASHP “So pharmacists must be in- HQID set of care processes in 2003, it could have result. volved in any performance measurement initiative such as ed in nearly 5,652 fewer deaths; 6,000 fewer complicathis one. In most such projects, the vast majority of qual- tions; 10,000 fewer readmissions; and one million fewer ity indicators involve medication management.” days in the hospital nationwide—and hospital costs could “QUEST: High Performing Hospitals” is a compre- have been as much as $1.4 billion lower. hensive three-year project. Participating hospitals will reQUEST is being conducted with the participation of port data to Premier on clearly defined performance the Institute for Healthcare Improvement in Boston. measures related to quality, efficiency, safety, and patient IHI’s “5 Million Lives” campaign is an ongoing voluntary satisfaction. Premier plans to analyze the data, share best initiative to protect patients from five million incidents of practices, and ultimately provide incentives for hospitals medical harm between December 2006 and December in the top quartile. It is now creating an advisory board to 2008. IHI is offering technical assistance and improvehelp supervise the project and seeking hospitals willing to ment expertise to the QUEST program. participate. (QUEST is an acronym for Quality, Efficien- THE AUTHOR is a writer based in Gettysburg, Pa. cy, Safety, with Transparency.) “We absolutely plan to have pharmacist particPremier outlines project goals ipation on the advisory board,” said Scott Pope, Pharm.D., a project director with Premier. “They QUEST is a three-year performance-measurement project being conducted by the healthcare alliance Premier Inc. that is just getting will be strongly involved in molding and defining under way. Its five measurement areas are: specific measures.” A number of hospitals have already agreed to participate, including Geisinger •Mortality ratio, which will be risk-adjusted with a goal of eliminating all avoidable deaths Health System, Danville, Pa.; the Kettering Medical Center Network of Dayton, Ohio; and North •Appropriate care, which will measure the percentage of patients receiving “perfect care,” i.e., using nationally recognized evidenceMississippi Health Services, Tupelo, Miss. based measures. The QUEST project is based on the many principles used in the Hospital Quality Incentive •Efficiency, which will measure severity-adjusted cost per discharge, including all of the costs associated with each episode of acute care. Demonstration project (HQID), the recent payfor-performance initiative overseen by Premier •Harm avoidance, which is designed to mean the prevention of healthcare-associated infections and adverse drug events. “Many and the Centers for Medicare & Medicaid Sermeasures exist today in this area,” said a Premier spokesman. “Parvices. “We intend to build on that program,” said ticipating hospitals will evaluate a number of these measures to idenPeterson. HQID, begun in October 2003, in- tify those that have the greatest impact for use in QUEST.” volved more than 260 hospitals and 33 evidence- •Patient satisfaction, which will utilize the CMS Hospital Consumer based clinical quality measures. Participants sub- Assessment of Healthcare Providers and Systems (HCAHPS) patient mitted data to Premier and CMS on process and satisfaction measures. outcomes measures in five clinical areas: acute myocardial infarction, congestive heart failure, http://www.drugtopics.com
Table of Contents Feed for the Digital Edition of Drug Topics - October 22, 2007 Drug Topics - October 22, 2007 Contents Latebreakers Legislative Victory Builds Momentum for Pharmacy Month Letters Health-System Edition R.Ph.s Brace for Payment Denial for Hospital-Acquired Conditions Topical Human Thrombin Helps Arrest Bleeding FDA Panels Fail to Set Target Levels for Renal Patients’ Hemoglobin Warning Letters Raise Patient Safety Concerns for Fentora Ending/Reversing Weight Gain Man Given Fatal Drug Overdose at Staten Island Hospital Pharmacists Playing More Important Role in Dialysis Treatment AHA President R.Ph.'s Here's How You Can Increase Your Value Premier Launches Comprehensive Quality Improvement Project FDA Approves Dexrazoxane for Treatment of Extravasation New Federal, State Reforms to Ease Disaster Relief Kinks 150 Years of American Pharmacy Ten Tips for MTM Success Independent Superstars: The Ones to Watch The New Dynamic Duo A Parkinson's Disease Primer Classified New Products Advertisers Index Viewpoint Drug Topics - October 22, 2007 Drug Topics - October 22, 2007 - Drug Topics - October 22, 2007 (Page Cover1) Drug Topics - October 22, 2007 - Drug Topics - October 22, 2007 (Page Cover2) Drug Topics - October 22, 2007 - Drug Topics - October 22, 2007 (Page 1) Drug Topics - October 22, 2007 - Contents (Page 2) Drug Topics - October 22, 2007 - Contents (Page 3) Drug Topics - October 22, 2007 - Contents (Page 4) Drug Topics - October 22, 2007 - Contents (Page 5) Drug Topics - October 22, 2007 - Latebreakers (Page 6) Drug Topics - October 22, 2007 - Latebreakers (Page 7) Drug Topics - October 22, 2007 - Legislative Victory Builds Momentum for Pharmacy Month (Page 8) Drug Topics - October 22, 2007 - R.Ph.s Brace for Payment Denial for Hospital-Acquired Conditions (Page H1) Drug Topics - October 22, 2007 - R.Ph.s Brace for Payment Denial for Hospital-Acquired Conditions (Page H2) Drug Topics - October 22, 2007 - R.Ph.s Brace for Payment Denial for Hospital-Acquired Conditions (Page H3) Drug Topics - October 22, 2007 - Topical Human Thrombin Helps Arrest Bleeding (Page H4) Drug Topics - October 22, 2007 - Topical Human Thrombin Helps Arrest Bleeding (Page H5) Drug Topics - October 22, 2007 - FDA Panels Fail to Set Target Levels for Renal Patients’ Hemoglobin (Page H6) Drug Topics - October 22, 2007 - FDA Panels Fail to Set Target Levels for Renal Patients’ Hemoglobin (Page H7) Drug Topics - October 22, 2007 - Warning Letters Raise Patient Safety Concerns for Fentora (Page H8) Drug Topics - October 22, 2007 - Warning Letters Raise Patient Safety Concerns for Fentora (Page H9) Drug Topics - October 22, 2007 - Ending/Reversing Weight Gain (Page H10) Drug Topics - October 22, 2007 - Man Given Fatal Drug Overdose at Staten Island Hospital (Page H11) Drug Topics - October 22, 2007 - Man Given Fatal Drug Overdose at Staten Island Hospital (Page H12) Drug Topics - October 22, 2007 - Man Given Fatal Drug Overdose at Staten Island Hospital (Page H13) Drug Topics - October 22, 2007 - Man Given Fatal Drug Overdose at Staten Island Hospital (Page H14) Drug Topics - October 22, 2007 - Pharmacists Playing More Important Role in Dialysis Treatment (Page H15) Drug Topics - October 22, 2007 - Pharmacists Playing More Important Role in Dialysis Treatment (Page H16) Drug Topics - October 22, 2007 - Pharmacists Playing More Important Role in Dialysis Treatment (Page H17) Drug Topics - October 22, 2007 - Pharmacists Playing More Important Role in Dialysis Treatment (Page H18) Drug Topics - October 22, 2007 - Pharmacists Playing More Important Role in Dialysis Treatment (Page H19) Drug Topics - October 22, 2007 - AHA President R.Ph.'s Here's How You Can Increase Your Value (Page H20) Drug Topics - October 22, 2007 - AHA President R.Ph.'s Here's How You Can Increase Your Value (Page H21) Drug Topics - October 22, 2007 - AHA President R.Ph.'s Here's How You Can Increase Your Value (Page H22) Drug Topics - October 22, 2007 - Premier Launches Comprehensive Quality Improvement Project (Page H23) Drug Topics - October 22, 2007 - Premier Launches Comprehensive Quality Improvement Project (Page H24) Drug Topics - October 22, 2007 - Letters (Page 9) Drug Topics - October 22, 2007 - FDA Approves Dexrazoxane for Treatment of Extravasation (Page 10) Drug Topics - October 22, 2007 - FDA Approves Dexrazoxane for Treatment of Extravasation (Page 11) Drug Topics - October 22, 2007 - New Federal, State Reforms to Ease Disaster Relief Kinks (Page 12) Drug Topics - October 22, 2007 - New Federal, State Reforms to Ease Disaster Relief Kinks (Page I1) Drug Topics - October 22, 2007 - New Federal, State Reforms to Ease Disaster Relief Kinks (Page I2) Drug Topics - October 22, 2007 - 150 Years of American Pharmacy (Page 13) Drug Topics - October 22, 2007 - Ten Tips for MTM Success (Page 14) Drug Topics - October 22, 2007 - Ten Tips for MTM Success (Page 15) Drug Topics - October 22, 2007 - Independent Superstars: The Ones to Watch (Page 16) Drug Topics - October 22, 2007 - Independent Superstars: The Ones to Watch (Page I3) Drug Topics - October 22, 2007 - Independent Superstars: The Ones to Watch (Page I4) Drug Topics - October 22, 2007 - Independent Superstars: The Ones to Watch (Page 17) Drug Topics - October 22, 2007 - Independent Superstars: The Ones to Watch (Page 18) Drug Topics - October 22, 2007 - Independent Superstars: The Ones to Watch (Page 19) Drug Topics - October 22, 2007 - The New Dynamic Duo (Page 20) Drug Topics - October 22, 2007 - The New Dynamic Duo (Page 21) Drug Topics - October 22, 2007 - The New Dynamic Duo (Page 22) Drug Topics - October 22, 2007 - The New Dynamic Duo (Page 23) Drug Topics - October 22, 2007 - The New Dynamic Duo (Page 24) Drug Topics - October 22, 2007 - The New Dynamic Duo (Page 25) Drug Topics - October 22, 2007 - A Parkinson's Disease Primer (Page 26) Drug Topics - October 22, 2007 - A Parkinson's Disease Primer (Page 27) Drug Topics - October 22, 2007 - A Parkinson's Disease Primer (Page 28) Drug Topics - October 22, 2007 - A Parkinson's Disease Primer (Page 29) Drug Topics - October 22, 2007 - A Parkinson's Disease Primer (Page 30) Drug Topics - October 22, 2007 - A Parkinson's Disease Primer (Page 31) Drug Topics - October 22, 2007 - A Parkinson's Disease Primer (Page 32) Drug Topics - October 22, 2007 - A Parkinson's Disease Primer (Page 33) Drug Topics - October 22, 2007 - A Parkinson's Disease Primer (Page 34) Drug Topics - October 22, 2007 - A Parkinson's Disease Primer (Page 35) Drug Topics - October 22, 2007 - Classified (Page 36) Drug Topics - October 22, 2007 - Classified (Page 37) Drug Topics - October 22, 2007 - Advertisers Index (Page 38) Drug Topics - October 22, 2007 - Advertisers Index (Page 39) Drug Topics - October 22, 2007 - Viewpoint (Page 40) Drug Topics - October 22, 2007 - Viewpoint (Page Cover3) Drug Topics - October 22, 2007 - Viewpoint (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.